Status:
COMPLETED
A Trial of Neurofeedback as an Adjunctive Treatment for Youth in Outpatient Mental Health Settings
Lead Sponsor:
University of Rochester
Conditions:
Trauma
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
The purpose of this study is to test the feasibility and effectiveness of a neurofeedback intervention conducted as an adjunctive behavioral health treatment to reduce trauma and affective symptoms in...
Eligibility Criteria
Inclusion
- (children)
- caregiver-reported exposure to two or more ACE types on the ACE-Q-Child measure.
- ages of 6-12 years old
- receiving or eligible to receive trauma-focused cognitive behavior therapy or another type of trauma-focused therapy, as determined by their primary therapist, designated as the TAU condition
- speaks and reads English
- (caregivers)
- own an iPhone, iPad, smartphone, or tablet that is equipped with Bluetooth and uses an Apple or Android operating system that is compatible with the MUSE Calm app and accompanying MUSE wearable neurofeedback device
- speaks and read English
Exclusion
- Child-caregiver dyads will be excluded if
- the child falls outside of the required age range,
- has a documented history of epilepsy
- is currently considered to be at high risk for suicide attempt
- is currently experiencing psychosis
Key Trial Info
Start Date :
February 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04871009
Start Date
February 28 2022
End Date
August 1 2025
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642